CFS Investment Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$547K Sell
9,415
-88
-0.9% -$5.05K 0.04% 247
2026
Q1
$572K Buy
9,503
+172
+2% +$10K 0.04% 241
2025
Q4
$503K Sell
9,331
-2,066
-18% -$99.4K 0.04% 238
2025
Q3
$500K Sell
11,397
-802
-7% -$37.5K 0.04% 234
2025
Q2
$565K Sell
12,199
-13,350
-52% -$655K 0.05% 218
2025
Q1
$1.56M Buy
25,549
+858
+3% +$50K 0.14% 128
2024
Q4
$1.4M Sell
24,691
-3,479
-12% -$194K 0.13% 132
2024
Q3
$1.46M Buy
28,170
+3,662
+15% +$172K 0.12% 127
2024
Q2
$1.02M Buy
+24,508
New +$1.1M 0.08% 142
2023
Q3
Sell
-14,280
Closed -$913K 164
2023
Q2
$913K Buy
+14,280
New +$958K 0.12% 125
2022
Q3
Sell
-7,603
Closed -$585K 247
2022
Q2
$585K Sell
7,603
-545,599
-99% -$41.6M 0.09% 155
2022
Q1
$8K Buy
553,202
+545,568
+7,147% +$36.6M 0.03% 168
2021
Q4
$495K Buy
7,634
+4,121
+117% +$242K 0.07% 164
2021
Q3
$208K Buy
+3,513
New +$231K 0.03% 192

Other funds holding BMY

CFS Investment Advisory Services's BMY Position: Q2 2026 in Review

CFS Investment Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 0.93% in Q2 2026, selling an estimated $5.05K and leaving 9,415 shares worth $547K. The position accounts for 0.04% of the portfolio, ranked #247.

CFS Investment Advisory Services first reported a position in BMY in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.56M in Q1 2025. 922 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • CFS Investment Advisory Services held 9,415 shares of Bristol-Myers Squibb worth $547K as of Q2 2026.
  • CFS Investment Advisory Services sold 88 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.05K.
  • Bristol-Myers Squibb made up 0.04% of CFS Investment Advisory Services's portfolio in Q2 2026, its #247 holding.
  • CFS Investment Advisory Services first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 14 quarters since.
  • CFS Investment Advisory Services's Bristol-Myers Squibb position peaked at $1.56M in Q1 2025.
  • 922 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on CFS Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.